Infliximab therapy in an infant with Netherton Syndrome.
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric dermatology"
DOI: 10.1111/pde.14590
Abstract: We present a patient with Netherton syndrome and severe skin manifestations treated with infliximab. By 6 months of age, the child had intractable pruritus, scaling, dry skin, and generalized eczematous lesions resistant to conventional therapies for… read more here.
Keywords: therapy infant; skin; infliximab therapy; netherton syndrome ... See more keywords